💥Join UPSC 2027,2028 Mentorship (August Batch) + XFactor Notes & Microthemes PDF

Subject: Science and Technology

  • Botrytis Fungus and Wine-Making

    Why in the News?

    Scientists have found that Botrytis cinerea, the fungus used in high-end sweet wines, cannot be cloned because none of its nuclei carry a full set of chromosomes, a rare genetic trait among fungi.

    About Botrytis Fungus:

    • Overview: Botrytis cinerea, also called noble rot, is a fungus that infects ripe grapes and causes them to shrivel while concentrating sugar and flavour.
    • Fungal Classification: It belongs to the ascomycetes group and produces spores in sac-like structures known as asci, each containing eight ascospores.
    • Role in Winemaking: Under controlled vineyard conditions, Botrytis infection is desirable, as it enhances the sweetness and aroma of wine.
    • How is Wine Made Using It?
      • Effect on Grapes: The fungus dehydrates the grapes, which increases the sugar content and concentrates flavours naturally.
      • Harvesting Method: Grapes affected by Botrytis are hand-harvested, making the process labour-intensive and expensive.
      • Wine Varieties Produced: It is used to produce premium dessert wines such as Sauternes (France), Tokaji Aszú (Hungary), and Trockenbeerenauslese (Germany), known for their complex flavours and high value.

    Significance of Recent Findings:

    • Cloning Discovery: A recent study in Science found that Botrytis cannot be cloned, as no single nucleus contains a full set of chromosomes.
    • Unique Genome Structure: The chromosomes are distributed across multiple nuclei, which is unprecedented in any known fungus, animal, or plant.
    • Scientific Impact: This challenges conventional genetics and may lead to new insights in genome organisation and fungal evolution.
    • Dual Importance: Botrytis is now seen not only as a key player in winemaking but also as a genetic curiosity in modern science.
    [UPSC 2009] In the context of alternative sources of energy, ethanol as a viable bio-fuel can be obtained from:

    (a) Potato (b) Rice (c) Sugarcane* (d) Wheat

     

  • National Statistics Day

    Why in the News?

    June 29 is observed annually as National Statistics Day in India to commemorate the birth anniversary of Prasanta Chandra Mahalanobis, hailed as the Father of Indian Statistics.

    About National Statistics Day:

    • Purpose: National Statistics Day is observed on June 29 each year to commemorate the birth anniversary of P.C. Mahalanobis and highlight the value of statistics in national development.
    • First Observance: It was first celebrated in 2007, following a government resolution to raise awareness about the role of statistics in socio-economic planning.
    • Objectives: It aims to emphasise the use of statistical tools in governance, policy-making, and development planning.
    • Organizers: Events are led by the Ministry of Statistics and Programme Implementation (MoSPI) and the Indian Statistical Institute (ISI).
    • Annual Themes: Each year features a dedicated theme focusing on a statistical challenge or development goal.
    • Events and Outreach: Celebrations include seminars, exhibitions, competitions, and lectures across institutions.
    • Commemorative Status: Though not a public holiday, it is a nationally recognized observance.

    Who was P.C. Mahalanobis?

    • Background: He was born on June 29, 1893, in Kolkata, into a Brahmo Samaj family.
    • Education: He studied at Presidency College and later at King’s College, Cambridge.
    • Legacy Title: He is hailed as the Father of Modern Statistics in India and was known as “The Professor”.
    • Institution Builder: He founded the Indian Statistical Institute (ISI) and helped set up India’s Planning Commission.
    • His Major Contributions:
      • National Sample Survey (NSS): Launched in 1950, it enabled the systematic collection of household data for policymaking.
      • Mahalanobis Distance: Introduced in 1936, it remains a widely used statistical tool for identifying outliers in data.
      • Applied Statistics: He applied statistical methods to flood control in Bengal and Odisha, offering cost-effective solutions.
      • Planning Vision: Mahalanobis played a key role in drafting the Second Five-Year Plan, focusing on industrialisation and state-led growth.
      • Academic Promotion: He started the journal Sankhya, modeled on Biometrika, to foster statistical research in India.
      • Infrastructure Vision: His early proposal led to the Hirakud Dam project, completed in 1957.
      • Balanced Approach: Though viewed as pro-Soviet during the Cold War, he was admired for his intellectual integrity.
    [UPSC 2016] A recent movie titled The Man Who Knew Infinity is based on the biography of:

    (a) S. Ramanujan (b) S. Chandhrashekhar (c) S. N. Bose (d) C. V. Raman

     

  • [pib] Researchers validate Optical Properties of Teak Leaf Extracts

    Why in the News?

    In a breakthrough, scientists at the Raman Research Institute (RRI) have found that teak leaf extract (Tectona grandis) could offer a natural, sustainable solution for laser protection.

    About Optical Properties of Teak Leaf:

    • Natural Composition: Teak leaves (Tectona grandis) contain natural compounds that can interact with strong laser light.
    • Laser Blocking Ability: These compounds can block harmful laser rays while allowing normal light to pass, making them suitable for selective light filtering.
    • Nonlinear Optics: This unique behaviour is called a nonlinear optical property, where a material responds differently to high-intensity light.
    • Linear vs Nonlinear: In linear optics, the material’s response is directly proportional to the light’s intensity. In nonlinear optics, the response becomes non-proportional, especially under laser exposure.

    Back2Basics: Teak as Timber in India

    • Teak (Tectona grandis) is a large deciduous hardwood tree native to India and Southeast Asia, mainly found in tropical dry and moist deciduous forests.
    • It is highly valued for its durable, strong, and water- and pest-resistant wood, making it the “King of Timbers”.
    • India manages 35% of the world’s planted teak forests, with major natural habitats in Madhya Pradesh, Maharashtra, Karnataka, Tamil Nadu, and Kerala.
    • Teak is listed as Endangered on the IUCN Red List but is not under CITES; private plantations are crucial for meeting demand due to restrictions on commercial felling in government forests.
    • Green felling is prohibited in government forests under the Forest Conservation Act, 1980, and National Forest Policy, 1988, with timber supply to be met mainly from dead/diseased trees or private plantations.

    Recent Breakthrough:

    • New Discovery: Scientists discovered that teak leaf extract can function as a natural laser shield.
    • Protection Potential: The extract can block high-intensity laser beams, offering protection to human eyes and sensitive optical devices.
    • First of Its Kind: This marks the first known instance of a natural material exhibiting such laser-blocking properties.

    Significance for Humans:

    • Practical Applications: It can be used in laser safety goggles, optical sensors, and other light-sensitive technologies.
    • Safe Alternative: It offers a non-toxic, eco-friendly substitute to chemical-based laser protection materials.
    • Sustainability Impact: The use of plant-based materials supports cost reduction and promotes sustainable innovation in science and optics.
    [UPSC 2015] In India, in which one of the following types of forests is teak a dominant tree species?

    Options: (a) Tropical moist deciduous forest* (b) Tropical rain forest (c) Tropical thorn scrub forest (d) Temperate Forest with grasslands

     

  • Type 2 diabetes rising among young people, posing lifetime risks: Lancet

    Why in the News?

    A new series by The Lancet highlights a major shift in global health. Type 2 diabetes, which earlier affected mostly older people, is now increasing quickly among those under 40. Around 260 million young adults worldwide already have the disease.

    What distinguishes early-onset type 2 diabetes from adult-onset in impact?

    • Longer disease duration with increased complications: Being diagnosed at a younger age means living longer with the disease, increasing the risk of complications like kidney failure, heart disease, and nerve damage throughout life. A 25-year-old with diabetes may face multiple health issues by age 40, compared to someone diagnosed at 55.
    • Greater loss in life expectancy: Individuals diagnosed before the age of 30 can lose up to 15 years of life expectancy, whereas older adults diagnosed later typically lose fewer years. A young adult may not survive past their 60s if the disease is poorly managed, while an older adult may live well into their 70s or 80s.
    • More disruption to personal and economic life: Early onset affects critical life stages like education, job opportunities, and family planning, placing greater mental and financial stress. A person in their 20s may have to drop out of college or limit employment due to frequent medical care needs.

    Why is early-onset diabetes a major concern for Indian health systems?

    • Rising burden on already stretched public healthcare: India’s healthcare system is under pressure from both infectious and non-communicable diseases. Early-onset diabetes increases the demand for long-term care, monitoring, and medication. A 2023 ICMR study found that more than 25% of diabetes cases in India are now diagnosed before the age of 40.
    • Economic impact on productivity and workforce: Early-onset diabetes reduces an individual’s healthy working years and impacts productivity, especially in labour-intensive sectors. According to the ICMR 2023 study, diabetic workers lose an average of 7–8 additional workdays annually, leading to reduced output, absenteeism, and rising employer costs.
    • Greater lifetime healthcare costs and complications: Early diagnosis leads to decades-long care, including medication, check-ups, and complication management, increasing costs for families and public health insurance. Eg: A young diabetic using insulin, requiring eye and kidney screenings, adds a heavy burden on schemes like Ayushman Bharat.

    How do socio-economic and environmental factors drive its rise?

    • Unhealthy food environments and marketing: Easy availability and aggressive marketing of processed and sugary foods through social media influence poor dietary habits among youth. Eg: Fast food delivery apps and influencer-driven trends promote ultra-processed snacks in urban areas like Delhi and Mumbai.
    • Inequality in access to healthcare and lifestyle management: Low-income groups lack access to nutritious food, safe exercise spaces, and preventive healthcare, increasing risks of obesity and diabetes. Eg: Children in urban slums of Kolkata face limited health awareness and inactivity, raising early-onset diabetes risk.
    • Impact of early-life undernutrition and developmental challenges: Poor maternal nutrition, low birth weight, and childhood undernourishment raise the chance of developing type 2 diabetes later, even without obesity. Eg: In rural Madhya Pradesh, undernourished children show insulin resistance despite having a low BMI.

    Why is prevention more effective than treatment in tackling this issue?

    • Reduces lifelong health burden and complications: Preventing diabetes avoids decades of medication, monitoring, and risks of complications like kidney or heart disease. Eg: Promoting physical activity and healthy diets in schools can reduce diabetes risk and future hospital visits.
    • More cost-effective for individuals and health systems: Prevention strategies like awareness campaigns and food policies cost less than long-term drug therapy and hospitalisation. Eg: Taxing sugar-sweetened beverages, adopted in over 100 countries, has reduced sugary drink sales and lowered obesity-related costs.
    • Addresses root causes and promotes healthy behaviours: Focusing on prevention changes social and environmental conditions that lead to obesity and diabetes. Eg: Urban planning with parks, pedestrian paths, and fitness centres encourages active lifestyles, lowering diabetes risk.

    Way forward:

    • Strengthen preventive public health strategies: Implement nationwide programs promoting healthy eating, physical activity, and early screening in schools and communities to reduce risk factors from a young age.
    • Ensure equitable access to care and awareness: Expand access to affordable diagnosis, lifestyle counselling, and essential medicines in both urban and rural areas, especially targeting low-income and high-risk groups.

    Mains PYQ:

    [UPSC 2022] The increase in life expectancy in the country has led to newer health challenges in the community. What are those challenges, and what steps need to be taken to meet them?

    Linkage: This question directly addresses “newer health challenges” and the steps required to meet them. The need for “urgent investment in prevention, early diagnosis and targeted care” mentioned in the article directly aligns with the “steps to be taken” aspect of this question.

  • Agricultural Fungicides causing C. Tropicalis Infections

    Why in the News?

    Researchers at Fudan University found that overuse of the fungicide tebuconazole is causing azole-resistant Candida tropicalis to emerge — a deadly fungus with a 55–60% mortality rate.

    About Candida tropicalis:

    • Overview: Candida tropicalis is a fungal pathogen prevalent in tropical and subtropical regions, including India.
    • Type: It is a yeast species that causes invasive candidiasis, affecting the bloodstream and internal organs.
    • High-Risk Groups: The fungus is opportunistic, primarily infecting immunocompromised individuals such as cancer patients and those in ICUs.
    • Mortality Rate: The infection has a high mortality rate, estimated at 55–60% when it becomes systemic.
    • Drug Treatment: Standard treatments include azole-class antifungals such as fluconazole and voriconazole (widely used during COVID-19 induced Black Fungus).
    • Adaptability: The pathogen shows strong genomic plasticity, allowing it to survive hostile environments and develop drug resistance.

    Reasons for Spread and Resistance:

    • Agricultural Influence: Studies show that azole fungicides like tebuconazole, used in farming, contribute to azole-resistant C. tropicalis
    • Environmental Exposure: These fungicides accumulate in soil and water, promoting the evolution of resistant strains.
    • Genetic Adaptations: Resistant strains develop aneuploidy (extra chromosomes), aiding resistance but reducing growth in drug-free environments.
    • Efflux Pumps: Some strains duplicate genes like TAC1, boosting drug-efflux pumps (e.g., ABC transporters) to eject antifungals from the cell.
    • Increased Virulence: Resistant strains have proven more virulent in animal studies, posing greater public health risks.

     

  • Substandard Cancer Drugs: A Global Public Health Alarm

    Why in the News?

    A global investigation has revealed that vital chemotherapy drugs used in over 100 countries have failed quality tests, posing life-threatening risks to cancer patients.

    Various Drugs Used for Cancer Treatment:

    • Cisplatin is a platinum-based drug discovered in the 1960s. It binds to DNA in cancer cells and is widely used to treat testicular, ovarian, bladder, and lung cancers. It is known to cause kidney damage, hearing loss, and immune suppression.
    • Oxaliplatin is another platinum compound mainly used to treat advanced colorectal cancer. It works similarly to cisplatin but may also cause nerve-related side effects.
    • Cyclophosphamide is used for treating breast cancer, leukaemia, sarcoma, and lymphoma. It damages cancer cell DNA and lowers white blood cell counts, weakening the immune system. It can also cause bladder inflammation.
    • Doxorubicin, known as the “Red Devil”, is derived from soil bacteria and used against breast cancer, leukaemia, and sarcomas. It disrupts DNA replication but has serious side effects, including heart damage and hair loss.
    • Methotrexate blocks enzymes involved in DNA synthesis and is used for leukaemia, lymphoma, and various tumors. It is often followed by leucovorin, which helps protect normal cells from damage.
    • Leucovorin is not a chemotherapy drug but a supportive agent used with methotrexate to reduce toxicity. It is a form of vitamin B9 introduced in the 1950s.

    Recent Quality Test Failure

    • Investigation: A 2024 investigation revealed that chemotherapy drugs sold in over 100 countries failed basic quality standards.
    • Failure of Generics: The drugs tested were generics. Also, 189 unexpired samples were tested; 20% failed.
    • Indian Pharma Under Radar: 17 manufacturers were flagged, with 16 based in India. Drugs failed for containing either too little (under 88%) or too much (over 112%) active ingredient.
    [UPSC 2005] It begins as a single cell and grows into a merciless disease that claims millions of lives year after year. But scientists are steadily unlocking its mysteries, and the fight against it may now have reached a dramatic turning point. New discoveries promise better therapies and hope in the war against …” The disease referred to in the above quotation is:

    Options: (a) Cancer (b) AIDS (c) Tuberculosis (d) Alzheimer’s disease

     

  • What is Axiom-4 Mission?

    Why in the News?

    The launch of Axiom-4 (Ax-4), a private mission to the International Space Station (ISS), has finally lifted-off after several postponements due to weather conditions.

    About Axiom-4 Mission:

    • Axiom Mission 4 (Ax-4) is a private spaceflight organized by Axiom Space.
    • It aims to transport a crew to the International Space Station (ISS) for a 14-day mission.
    • This will be Axiom Space’s 4th mission to the ISS, following their previous missions (Ax-1, Ax-2, and Ax-3).
    • The mission will launch from the Kennedy Space Center in Florida using SpaceX’s Falcon 9 rocket.
    • The spacecraft for this mission is a SpaceX Crew Dragon, known for its advanced technology and safety features.
    • This mission is organised in collaboration with NASA, highlighting a strong partnership between private space companies and government space agencies to further space exploration and research.
    • Crew:
      1. Peggy Whitson: A veteran astronaut with extensive experience, having completed multiple missions to the ISS.
      2. Sławosz Uznanski: A Polish astronaut joining the mission, marking a significant milestone for Poland in space exploration.
      3. Tibor Kapu: A Hungarian astronaut, adding to the diversity of the mission crew.
      4. Group Captain Shubhanshu Shukla: An Indian astronaut, making headlines as part of this international crew.

    Significance of Ax-4 Mission for India

    • The mission is a collaborative effort resulting from an agreement between ISRO and NASA.
    • It provides ISRO with an early opportunity to test experiments in space, originally planned for Gaganyaan.
    • Key Indian Experiments on Axiom-4:
      • Microgravitys impact on muscle dysfunction.
      • Use of computer screens in zero gravity and their effects on human cognition and vision.
      • Growth of six varieties of crop seeds in space conditions.
      • Tardigrade survival study—these microscopic creatures can endure extreme environments and may provide insight into life support systems in space.

    Back2Basics: International Space Station (ISS)

    • The ISS, orbiting 430 kilometres above Earth, completes 16 orbits daily, witnessing 16 sunrises and sunsets.
    • It orbits Earth every 90 minutes at 8 km per second.
    • Spanning 109 meters, it’s almost as long as an American football field.
    • It includes 6 sleeping areas, 2 bathrooms, a gym, and a panoramic view bay window.
    • Its solar array wingspan is 109 meters, and the station houses about 13 km of electrical wiring.
    • Its journey began on November 20, 1998, with Russia’s Zarya Control Module.
    • The US added the Unity Node 1 module on December 4, 1998, marking the start of a functional space lab.
    • It evolved into its current form after 42 assembly flights.

     

    PYQ:

    [2019] What is India’s plan to have its own space station and how will it benefit our space programme?

  • Sam Altman’s World ID Project

    Why in the News?

    World ID is Sam Altman’s ambitious project to create a secure, biometric-based digital identity for everyone in the age of AI.

    What is World ID?

    • World ID is a digital identity system launched by Sam Altman’s company Tools for Humanity as part of the Worldcoin project in July 2023.
    • It aims to verify that a person is a real, unique human being—especially in an age of AI-generated bots—using biometric iris scans.
    • How Does It Work?
      • The identity is created using a device called the Orb, which captures the iris pattern and generates a unique cryptographic code (not storing the image itself).
      • This ID is then linked to the World App, and the user can access various services while proving they are human—without revealing their actual identity.
      • The system is decentralized and uses blockchain technology to store identity proofs securely.

    Key Features of World ID:

    • Biometric Verification: Uses iris scanning through the Orb to establish a unique identity.
    • Global Access: Users from over 160 countries have access to Worldcoin and World ID features.
    • Decentralized Protocol: Built on open-source, privacy-preserving cryptography, such as zero-knowledge proofs.
    • World App Integration: Enables users to locate Orbs, receive Worldcoins, and use the digital ID across apps.
    • World Chain: A blockchain linked to World ID that supports apps and services tied to identity.
    • Crypto Incentive: Users may receive Worldcoin (WLD) tokens for enrolling.
    • Privacy Controls: Promises anonymity, non-surveillance use, and code transparency.
    • Hardware Dependency: Requires a physical Orb or the new Orb Mini to generate IDs.

    How it differs from Aadhaar?

    World ID Aadhaar
    Ownership Private project by Tools for Humanity Government of India
    Launch Year 2023 2009
    Technology Used Iris scan via Orb; Blockchain-based ID Biometric + Demographic data via central database
    Legal Framework No national law backing it yet Aadhaar Act, 2016
    Purpose Global ID to prove human uniqueness National ID for accessing services & welfare
    Data Privacy Claims privacy via zero-knowledge cryptography Data regulated by UIDAI under Indian law
    Adoption Level 12 million users globally Over 1.3 billion users in India
    Hardware Needed Orb device Fingerprint/iris scanners at enrollment centers
    Verification Use AI-bot detection, global ID use Government subsidies, banking, KYC, etc.

     

  • In-Body CAR T-Cell Therapy

    Why in the News?

    A new study published in Science journal shows that “In-Body CAR T-Cell Therapy” marks a breakthrough by enabling direct immune cell reprogramming for faster, safer treatment of cancer and autoimmune diseases.

    What is CAR T-Cell Therapy?

    • Overview: CAR T-cell therapy is a treatment where a patient’s own T cells are genetically modified to detect and kill cancer cells.
    • Science behind it: Scientists extract T cells and add a Chimeric Antigen Receptor (CAR) gene, which enables them to identify cancer cells.
    • Working: These modified T cells are infused back into the patient, where they multiply and actively attack cancer.
    • Effectiveness: The therapy has shown high success against certain blood cancers and is now being studied for autoimmune disorders like lupus.
    • Issues: The traditional therapy is expensive (₹60–70 lakh), slow, and requires chemotherapy and specialised lab facilities.

    Recent Breakthrough: In-Body CAR T-Cell Therapy

    • Approach: A new technique uses mRNA-loaded lipid nanoparticles (LNPs) to deliver instructions directly inside the body.
    • Targeting Cells: These nanoparticles are programmed to locate and enter killer T cells, converting them into CAR T-cells internally.
    • Benefits offered: This method eliminates the need for cell extraction, chemotherapy, or viral vectors, making it faster and safer.

    Significance for India:

    • Scalable Innovation: This platform may lower treatment costs and offer wider access in countries like India with high cancer and autoimmune burdens.
    • Infrastructure Relief: Its in-body nature avoids dependence on advanced labs, making it suitable for resource-constrained settings.
    [UPSC 2019] What is Cas9 protein that is often mentioned in news?

    Options: (a) A molecular scissors used in targeted gene editing* (b) A biosensor used in the accurate detection of pathogens in patients (c) A gene that makes plants pest-resistant (d) A herbicidal substance synthesized in genetically modified crops

     

  • India trails in critical tech, particularly semiconductor tech

    Why in the News?

    A new global index called the Critical and Emerging Technologies Index ranks 25 countries based on their strength in five key areas: AI, biotechnology, semiconductors, space, and quantum tech. India scored 15.2 overall, falling far behind top countries like the U.S., China, and those in Europe.

    What is the Critical and Emerging Technologies Index?

    • A global index launched to evaluate how 25 countries perform across five technology sectors: AI, biotechnology, semiconductors, space, and quantum.
    • Developed using public and commercial data, allowing policymakers to compare relative strengths and weaknesses.
    • Weighting of sectors: Semiconductors (35%), AI (25%), Biotechnology (20%), Space (15%), Quantum (5%), based on geopolitical relevance and dual-use potential.

    How does it assess countries’ performance?

    • Sector-wise Evaluation Using Pillars: Each of the five sectors—AI, biotechnology, semiconductors, space, and quantum—is assessed using multiple weighted pillars such as funding, talent, core technologies, infrastructure, and global influence.
    • Weighted Scoring System: The index assigns strategic weights to each sector (e.g., semiconductors 35%, AI 25%) based on geopolitical relevance and dual-use potential, resulting in an overall score that reflects each country’s relative technological strength.

    Why is India behind the top countries in key tech sectors?

    • Lower Investments and Talent Gaps: India lacks deep investments and a large skilled workforce in core tech sectors like semiconductors and quantum computing. Eg: The U.S. leads in AI and chip design due to massive R&D funding and strong academia-industry collaboration.
    • Fragmented Innovation Ecosystem: Unlike the U.S.’s decentralized model or China’s state-led coordination, India’s innovation lacks synergy across government, industry, and academia. Eg: India ranks below France and far behind China in biotech and space sectors despite policy efforts.
    • Limited Manufacturing and Infrastructure: India has weak chip fabrication and limited quantum labs or space tech facilities compared to countries like Taiwan (chips) or Russia (space assets). Eg: India ranks 7th in space while Russia is 3rd due to superior defence assets and launch capabilities.

    Which factors drive U.S. dominance in tech?

    • Massive Investments and Funding: The U.S. leads due to consistent and large-scale public and private investments in emerging technologies. Eg: Heavy funding in AI and semiconductors ensures global leadership in research and innovation.
    • Strong Talent and Research Ecosystem: A world-class workforce, top universities, and a decentralized innovation network strengthen its technological base. Eg: Institutions like MIT and Stanford produce cutting-edge research in quantum and biotech.
    • Strategic Global Partnerships: The U.S. collaborates closely with tech leaders like Japan, South Korea, and Europe, especially in semiconductorsand quantum. Eg: Joint ventures in chip production enhance U.S. resilience and global influence.

    How do China and Europe compare in tech strengths?

    Aspect China Europe Example
    Biotechnology Strong growth due to state-led investments and large talent pool Leading in vaccine R&D, genetic engineering, and pharma Eg: China’s focus on biotech parks; Europe’s mRNA vaccine leadership
    Quantum Technology Rapidly progressing with centralised planning and funding Strong academic research and early quantum computing breakthrough Eg: China’s Jiuzhang quantum computer; Europe’s QuTech (Netherlands)
    Semiconductors Lags behind due to foreign tech dependency and tool import barriers Moderate progress; behind East Asia and U.S. in manufacturing Eg: China’s reliance on ASML’s lithography; Europe’s low chip fab capacity
    Artificial Intelligence (AI) Excels in data volume and AI applications, but weaker algorithms Strong in ethical AI, policy, and funding, but lags behind in deployment Eg: China’s use of AI in facial recognition; Europe’s AI Act regulation
    Space Technology Advanced programs with state backing; lacks international openness Lower funding and limited military use; some success in space science Eg: China’s Chang’e missions; Europe’s ESA satellite projects

     

    Why is the above comparison between Europe and China important for India? 

    • Strategic Benchmarking for Policy and Investment: It helps India identify strength areas (e.g., biotech in Europe, quantum in China) and gaps (e.g., semiconductors) to shape its own technology roadmap, investments, and global collaborations. Eg: India can learn from China’s scale-driven investments in biotech and Europe’s regulatory models in AI for better domestic implementation.
    • Opportunity for Strategic Alliances: Understanding their strengths enables India to form targeted partnerships for tech transfer, research, and market access in complementary areas. Eg: India–EU cooperation in pharmaceutical innovation, or India–China dialogue in quantum research norms can enhance India’s tech footprint.

    Way forward: 

    • Enhance Strategic Investments in Core Tech Sectors: India should increase targeted funding and incentives in critical areas like semiconductors, AI, and biotech, with a focus on R&D, talent development, and infrastructure. Eg: Expanding PLI schemes to include quantum and chip design startups.
    • Build Global Tech Partnerships and Talent Pipelines: Proactively engage with Europe, Japan, South Korea, and the U.S. for joint research, mutual recognition of standards, and tech collaboration. Eg: Set up Indo-EU research hubs for biotechnology and semiconductor fabrication units with Japan.

    Mains PYQ:

    [UPSC 2022] Elucidate the relationship between globalization and new technology in a world of scarce resources, with special reference to India.

    Linkage: India “lags significantly” in critical technology sectors like semiconductors, which require substantial resources (e.g., advanced manufacturing capabilities, specialized raw materials, skilled talent, significant funding), this question implicitly probes India’s challenges and trailing position in the global technological landscape.